Epic Research Update : Aurobindo Pharma

Expect to be in top 10 companies in west Europe post acquisition

Acquisition does not bring any additional debt on company’s books

Acquisition timing well planned with company’s cash flows

Have repaid debt obligations of USD 65 million up to Q2

No more immediate debt deadline -Actavis operations have virtually no debt

Product Mix change will be immediate driver to improve EBITDA

For more information call- 0731-6642300 or Visit-http://goo.gl/g55v85

Posted in: Indian Market Tips